BlackRock, Inc. 13D and 13G filings for Lyell Immunopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 1:23 pm Sale | 2024-12-31 | 13G | Lyell Immunopharma, Inc. LYEL | BlackRock Inc. BLK | 663,293 4.500% | -51,818 (-7.25%) | Filing |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Lyell Immunopharma, Inc. LYEL | BlackRock Inc. BLK | 715,111 5.700% | 715,111 (New Position) | Filing |